Greg Chittick

432 total citations
9 papers, 292 citations indexed

About

Greg Chittick is a scholar working on Genetics, Epidemiology and Infectious Diseases. According to data from OpenAlex, Greg Chittick has authored 9 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Greg Chittick's work include Virus-based gene therapy research (7 papers), Cytomegalovirus and herpesvirus research (3 papers) and Herpesvirus Infections and Treatments (2 papers). Greg Chittick is often cited by papers focused on Virus-based gene therapy research (7 papers), Cytomegalovirus and herpesvirus research (3 papers) and Herpesvirus Infections and Treatments (2 papers). Greg Chittick collaborates with scholars based in United States, Mexico and Panama. Greg Chittick's co-authors include Thomas M. Brundage, W. Garrett Nichols, Marion E. Morrison, Genovefa A. Papanicolaou, Scott A. Foster, Francisco M. Marty, Roy F. Chemaly, Michael Boeckh, Drew J. Winston and Kathleen M. Mullane and has published in prestigious journals such as PEDIATRICS, Antiviral Research and Biology of Blood and Marrow Transplantation.

In The Last Decade

Greg Chittick

9 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Greg Chittick United States	5	211	110	102	73	54	9	292
Joseph Sassine United States	7	191 0.9×	110 1.0×	137 1.3×	57 0.8×	52 1.0×	30	277
Philip D. Yin United States	9	144 0.7×	68 0.6×	83 0.8×	92 1.3×	15 0.3×	14	299
Nadejda Valiaeva United States	10	141 0.7×	78 0.7×	33 0.3×	160 2.2×	30 0.6×	20	293
Ellen H. Nagami United States	7	186 0.9×	57 0.5×	103 1.0×	42 0.6×	11 0.2×	11	283
Prateek Choudhary United Kingdom	7	48 0.2×	92 0.8×	55 0.5×	44 0.6×	17 0.3×	8	337
Natasha Persaud United States	4	152 0.7×	79 0.7×	149 1.5×	60 0.8×	36 0.7×	5	366
Nathan Price United States	6	108 0.5×	28 0.3×	16 0.2×	35 0.5×	33 0.6×	11	181
Srividya Ramachandran United States	5	104 0.5×	68 0.6×	23 0.2×	78 1.1×	40 0.7×	5	297
Janina Bruening Germany	8	101 0.5×	55 0.5×	30 0.3×	108 1.5×	13 0.2×	11	313
Mayumi Imahashi Japan	9	103 0.5×	169 1.5×	184 1.8×	204 2.8×	14 0.3×	26	401

Countries citing papers authored by Greg Chittick

Since Specialization

Citations

This map shows the geographic impact of Greg Chittick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Chittick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Chittick more than expected).

Fields of papers citing papers by Greg Chittick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Chittick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Chittick. The network helps show where Greg Chittick may publish in the future.

Co-authorship network of co-authors of Greg Chittick

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Chittick. A scholar is included among the top collaborators of Greg Chittick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Chittick. Greg Chittick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Marty, Francisco M., Drew J. Winston, Roy F. Chemaly, et al.. (2018). A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(2). 369–381. 157 indexed citations

Brundage, Thomas M., Enrikas Vainorius, Greg Chittick, & Garrett Nichols. (2018). Brincidofovir Decreases Adenovirus Viral Burden, Which is Associated with Improved Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 24(3). S372–S372. 2 indexed citations

Chittick, Greg, Marion E. Morrison, Thomas M. Brundage, & W. Garrett Nichols. (2017). Short-term clinical safety profile of brincidofovir: A favorable benefit–risk proposition in the treatment of smallpox. Antiviral Research. 143. 269–277. 96 indexed citations

Prasad, Vinod K., Genovefa A. Papanicolaou, Gabriela Marón, et al.. (2017). Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (allo HCT) Patients (pts) with Brincidofovir: Final 36 Week Results from the Advise Trial. Biology of Blood and Marrow Transplantation. 23(3). S57–S58. 13 indexed citations

Grimley, Michael, Genovefa A. Papanicolaou, Vinod K. Prasad, et al.. (2016). Treatment of Adenovirus (AdV) Infection in Allogeneic Hematopoietic Cell Transplant (HCT) Patients (pts) with Brincidofovir: 24 Week Interim Results from the AdVise Trial. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations

Grimley, Michael, Gabriela Marón, Vinod K. Prasad, et al.. (2015). Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection. Biology of Blood and Marrow Transplantation. 21(2). S108–S109. 7 indexed citations

Florescu, Diana F., Michael Grimley, Eric Bourne, et al.. (2015). Brincidofovir (BCV) for the Treatment of Adenovirus (AdV) Infection in Patients Receiving Liver Transplantation (LT). Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations

Young, Jo‐Anne H., Michael Grimley, David A. Jacobsohn, et al.. (2014). LB-3Preliminary Safety Results and Antiviral Activity from the Open-label Pilot Portion of a Phase 3 Study to Evaluate Brincidofovir (BCV) for the Treatment of Adenovirus (AdV) Infection. Open Forum Infectious Diseases. 1(suppl_1). S67–S67. 1 indexed citations

Sáez‐Llorens, Xavier, Avy Violari, Ram Yogev, et al.. (2008). Long-term Safety and Efficacy Results of Once-Daily Emtricitabine-Based Highly Active Antiretroviral Therapy Regimens in Human Immunodeficiency Virus-Infected Pediatric Subjects. PEDIATRICS. 121(4). e827–e835. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact